Procter & Gamble Health

Procter & Gamble Health Debt/EBITDA

The Total Debt to EBITDA Ratio of Procter & Gamble Health (PGHL.NS) as of Nov 9, 2026 is 0.02. In the previous year, Total Debt to EBITDA Ratio was 0.01 — a change of 72.47% (higher).

Debt/EBITDA

0.02

YoY

72.47%

Last updated:

Total Debt to EBITDA Ratio of Procter & Gamble Health is 2025 0.02 . Total Debt to EBITDA Ratio of Procter & Gamble Health was 2024 0.01 . It decreases by 72.47% higher compared to the previous year.

The Procter & Gamble Health Debt/EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt/EBITDA
Date
Debt/EBITDA
Jan 1, 2017
0.03 INR
Jan 1, 2018
0.02 INR
Jan 1, 2019
0.02 INR
Jan 1, 2021
0.01 INR
Jan 1, 2022
0.02 INR
Jan 1, 2023
0.02 INR
Jan 1, 2024
0.01 INR
Jan 1, 2025
0.02 INR
The Procter & Gamble Health Debt/EBITDA history
YEARDebt/EBITDAYoY
0.02+72.47%
0.01-31.86%
0.02-17.27%
0.02+266.70%
0.01-76.29%
0.02+21.17%
0.02-23.58%
0.03-308.37%
-0.01-435.20%
0.00—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Procter & Gamble Health Stock analysis

What does Procter & Gamble Health do? Procter & Gamble Health Ltd. is a leading company in the health and hygiene products industry. The company was founded in 1837 by William Procter and James Gamble in Cincinnati, Ohio. Since then, the company has undergone incredible development and is now a global corporation with more than 95,000 employees and an annual revenue of nearly $70 billion. The business model of Procter & Gamble Health Ltd. is focused on providing customers with high-quality products at an affordable price. The company operates in various areas, including household products, health products, beauty products, and hygiene products. The different divisions of Procter & Gamble Health Ltd. include the following areas: Household products: Brands like Ariel, Ace, and Lenor are among the most well-known offerings from Procter & Gamble Health. The company is also active in the textile care category and offers various products such as the brand Downy. Health products: The company's health products focus on oral and dental care, as well as pain relief and digestive aids. Brands like Oral-B and Vick are among the most well-known in the portfolio. Beauty products: Procter & Gamble Health offers a wide range of beauty products such as shampoo, conditioner, and hair dye. Herbal Essences, Pantene, and Wella are among the most well-known brands in this area. Hygiene products: The company offers products such as toilet paper, diapers, and cleaning agents. Pampers, Charmin, and Swiffer are among the most well-known brands. Procter & Gamble Health Ltd. has a very extensive product portfolio, which also includes brands like Always, Old Spice, and Gillette. Procter & Gamble Health is an innovative company that continuously offers its customers new and improved products. An example of this is the development of Tide Pods, a novel way to wash laundry that is packaged in a completely soluble shell. In addition to continuous product development, the company also places great importance on sustainability and social responsibility. Procter & Gamble Health actively engages in environmental protection and advocates for the improvement of working conditions and quality of life for people worldwide. In summary, Procter & Gamble Health Ltd. is a successful company that enjoys an excellent reputation due to its innovative strength, extensive product range, and commitment to sustainability and social responsibility. Procter & Gamble Health is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Procter & Gamble Health stock

Total Debt to EBITDA Ratio of Procter & Gamble Health is 0.02 in 2025.

Total Debt to EBITDA Ratio of Procter & Gamble Health changed from 0.01 to 0.02, representing a 72.47% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Total Debt to EBITDA Ratio Procter & Gamble Health since 2006 – with annual values, charts, and detailed analysis.

Debt/EBITDA measures total debt relative to earnings before interest, taxes, depreciation, and amortization. It indicates the years needed to repay all debt from EBITDA.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Total Debt to EBITDA Ratio's Procter & Gamble Health with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Procter & Gamble Health

All Key Metrics — Procter & Gamble Health